Albert Bourla New York Germany covid-19 vaccine Health Albert Bourla New York Germany

Pfizer says COVID-19 booster restores vaccine efficacy to 95.6%

Reading now: 563
www.fox29.com

NEW YORK - Pfizer and its German partner BioNTech on Thursday shared results from the Phase 3 trial of their COVID-19 vaccine booster, saying the additional third dose showed 95.6% efficacy against symptomatic disease.The trial involved more than 10,000 people 16 and older who had previously received the Pfizer-BioNTech primary two-dose vaccine.

Pfizer said the booster "restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster." "These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," Pfizer CEO Albert Bourla said in a statement.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA